Intravitreal anti-vascular endothelial growth factor (VEGF) injections are widely used to treat various retinal conditions, including diabetic macular edema, age-related macular degeneration, and retinal vein occlusions. This evidence concerns the gene VEGFA and age-related macular degeneration.